High drug prices have created barriers to accessing medications, and Gerard Anderson, PhD, of Johns Hopkins Bloomberg School of Public Health, suggests that the pricing algorithms need to change in order to improve this dilemma.
High drug prices have created barriers to accessing medications, and Gerard Anderson, PhD, of Johns Hopkins Bloomberg School of Public Health, suggests that the pricing algorithms need to change in order to improve this dilemma.
Transcript (slightly modified)
What do you view as the biggest barrier to access to medications?
I’m really focused on the high cost drugs. So, for that it’s really the price and we basically have a system where only about 20% of the people can afford these very expensive drugs because a program like Medicare puts very high cost-sharing on it. Medicaid doesn’t typically cover them, the Bureau of Prisons, the Indian Health Services, don’t cover those things because they’re so expensive. So, I think the major problem that I am seeing right now for many people is the very high cost drugs. For a lot of people, they just don’t have any money at all and so even having a very little cost sharing is devastating. A program like the Patient Access Network is critical for them but I think what new situation that is happening is that the very expensive drugs have become the problem.
How can access be improved?
Essentially for the very high cost drugs, we need to figure out a way to get price times quantity down, so that the price is way down and the quantity is way up. Right now, the pricing algorithms that most of the drug companies have assume that very few people will buy the drug at a very high price, and from a public health point of view, we want a lower price but a much higher quantity so that the drug companies still have the same revenue, but we essentially get as many people as possible covered.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More